Co-Diagnostics, Inc.
On-site PCR diagnostic testing platform for rapid pathogen detection
- Sector
- Medtech
- Headquarters
- SALT LAKE CITY, UT
- Founded
- 2013
- Latest Form D
- $46.6M, Jan 2022
- Total capital
- $47.3M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $47.3M
- 2 Form D · last Jan 2022
- 57 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 1
- 17 pending · first 2025
- Rank in peer group#498 of 1112
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 2nd filing$46.6M
- Private capital raisedForm D · SEC · 1st filing$750K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 1112 peers
Line = medianMedtech · Device
- Granted patents#498 · top 45%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
From SEC Form D filings- Brent L. SatterfieldDirectorNamed in SEC Form D filings
- Brian BrownExecutive OfficerNamed in SEC Form D filings
- Dwight EganExecutive OfficerNamed in SEC Form D filings
- Reed L. BensonExecutive Officer, DirectorNamed in SEC Form D filings
What it has protected
USPTO · 1 granted of 18- GrantedAllele-specific Design Of Cooperative Primers For Improved Nucleic Acid Variant GenotypingUSPTOUS 12,258,620
- PendingMethods And Compositions Related To Cooperative Primers And Reverse TranscriptionUSPTOApplication 18566302
- PendingTertiary Cooperative Primers And Methods Of UseUSPTOApplication 18192914
Show all 18 patent records
- Allele-specific Design Of Cooperative Primers For Improved Nucleic Acid Variant GenotypingMar 25, 2025 · US 12,258,620Granted
- Methods And Compositions Related To Cooperative Primers And Reverse TranscriptionJun 6, 2024 · Application 18566302Pending
- Tertiary Cooperative Primers And Methods Of UseFeb 15, 2024 · Application 18192914Pending
- Methods And Systems For Analyzing Nucleic Acids Using Increased Ifret With Multiple Acceptor FluorophoresSep 7, 2023 · Application 18146051Pending
- Systems, Methods, And Apparatus For Automated Self-contained Biological AnalysisNov 3, 2022 · Application 17661813Pending
- Methods And Compositions For Next Generation Sequencing (ngs) Library PreparationMay 12, 2022 · Application 17605694Pending
- Rapid Oligo ProbesSep 7, 2017 · Application 15280304Pending
- Tertiary Cooperative Primers And Methods Of UseApplication 63325851Pending
- Methods And Systems For Analyzing Nucleic Acids Using Increased Ifret With Multiple Acceptor FluorophoresApplication 63295388Pending
- Methods And Systems For Analyzing Nucleic Acids Using Increased Ifret With Multiple Acceptor FluorophoresApplication 63294694Pending
- Methods And Compositions Related To Cooperative Primers And Reverse TranscriptionApplication PCTUS2022031913Pending
- Methods And Compositions Related To Cooperative Primers And Reverse TranscriptionApplication 63196004Pending
- Methods And Systems For Analyzing Nucleic Acids Using Increased Ifret With Multiple Acceptor FluorophoresApplication PCTUS2022082340Pending
- Methods And Compositions For Next Generation Sequencing (ngs) Library PreparationApplication PCTUS2020029727Pending
- Allele-specific Design Of Cooperative Primers For Improved Nucleic Acid Variant GenotypingApplication PCTUS2019052957Pending
- Methods And Compositions For Next Generation Sequencing (ngs) Library PreparationApplication 62838036Pending
- Allele-specific Design Of Cooperative Primers For Improved Nucleic Acid Variant GenotypingApplication 62736094Pending
- Tertiary Cooperative Primers And Methods Of UseApplication PCTUS2023065132Pending
Related companies, and why
- HeartHero, Inc.Similar federal contract value in Medtech · null in contracts
- Palarum LLCSimilar federal contract value in Medtech · null in contracts
- Immunostics, Inc.Similar federal contract value in Medtech · null in contracts
- AYUDA MEDICALSimilar federal contract value in Medtech · null in contracts
- RheoTek Medical LLCSimilar federal contract value in Medtech · null in contracts
- Renerva, LLCSimilar federal contract value in Medtech · null in contracts
Press
Co-Diagnostics Reports Second Quarter 2026 Financial ResultsPRNewswire
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .